Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Phase 2 Trial
Recent news which mentions Phase 2 Trial
< Previous
1
2
3
4
5
6
7
8
9
Next >
Clene Nanomedicine Presents Updated Data From Mid-Stage Amyotrophic Lateral Sclerosis Trials
March 14, 2022
Tickers
CLNN
Tags
Market News
Phase 2 Trial
General
From
Benzinga
BridgeBio Pharma Posts Updated Data From Muscular Dystrophy Trial, Plots Path To Market
March 14, 2022
Tickers
BBIO
Tags
Briefs
Benzinga
Biotech
From
Benzinga
Scholar Rock To Highlight Apitegromab Data From Ambulatory Cohort In Muscular Dystrophy
March 14, 2022
Tickers
SRRK
Tags
Market News
Health Care
SRRK
From
Benzinga
Why Sanofi Shares Are Trading Lower Today
March 14, 2022
Tickers
SNY
Tags
Health Care
Trading Ideas
SNY
From
Benzinga
Moderna Starts Dosing In Mid-Stage Omicron-Specific Bivalent Booster Candidate
March 10, 2022
Tickers
MRNA
Tags
COVID/19 Vaccine
General
Phase 2 Trial
From
Benzinga
FDA Gives Green Signal To Inventiva's Mid-Stage Lanifibranor Study In NASH Patients
March 08, 2022
Tickers
IVA
Tags
Phase 2 Trial
Market News
Small Cap
From
Benzinga
Alkermes' Nemvaleukin Shows Encouraging Anti-Tumor Activity In Pretreated Kidney Cancer
February 17, 2022
Tickers
ALKS
Tags
Benzinga
Biotech
Movers
From
Benzinga
Amgen Posts Latest Batch of Lumakras Data In Pancreatic Cancer
February 15, 2022
Tickers
AMGN
Tags
Pancreatic Cancer
Phase 1 Trial
Health Care
From
Benzinga
ImmunityBio's Ankitva Shows 100% Survival At Two Years In Bladder Cancer Setting
February 15, 2022
Tickers
ENDP
IBRX
MRK
Tags
Market News
IBRX
MRK
From
Benzinga
BioXcel BXCL701 Combo Therapy Shows Encouraging Response Rates In Prostate Cancer
February 15, 2022
Tickers
BTAI
MRK
Tags
News
Health Care
MRK
From
Benzinga
Opthea Shares OPT-302 data In Patients With Subtype Of Age-Related Macular Degeneration
February 14, 2022
Tickers
OPT
Tags
News
Briefs
Biotech
From
Benzinga
RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial
February 09, 2022
Tickers
RGNX
Tags
gene therapy
Health Care
Phase 1 Trial
From
Benzinga
4D Molecular Shares Updated Data From Fabry Disease Trial
February 09, 2022
Tickers
FDMT
Tags
General
Small Cap
Fabry disease
From
Benzinga
After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data
February 09, 2022
Tickers
AVRO
Tags
Penny Stocks
gene therapy
Health Care
From
Benzinga
Why Are NLS Pharmaceutics Shares Trading Higher During Premarket Monday?
February 07, 2022
Tickers
NLSP
Tags
News
NLSP
Health Care
From
Benzinga
Valneva - Pfizer Choose Three-Dose Schedule For Lyme Vaccine Candidate Moving Forward
February 04, 2022
Tickers
PFE
VALN
Tags
PFE
Briefs
News
From
Benzinga
Altimmune's Mid-Stage Pemvidutide Study Cleared By FDA For Obesity
January 31, 2022
Tickers
ALT
Tags
Phase 2 Trial
General
FDA
From
Benzinga
Kaleido Halts Upcoming Phase 2 COPD Trial, Piper Sandler Cuts Price Target
January 31, 2022
Tickers
JNJ
KLDO
Tags
Benzinga
Biotech
Briefs
From
Benzinga
Taysha Gene Plans Protocol Amendment After Patient Death In Gene Therapy Trial
January 27, 2022
Tickers
TSHA
Tags
Benzinga
Biotech
Movers
From
Benzinga
4D Pharma's Asthma Candidate Shows Positive Trends In Multiple Secondary Endpoints Of Efficacy
January 27, 2022
Tickers
LBPS
Tags
General
Phase 2 Trial
LBPS
From
Benzinga
Why Are Tyme Technologies Shares Staring At 52-Week Low
January 26, 2022
Tickers
TYME
Tags
Briefs
Movers
Biotech
From
Benzinga
Two Organizations To Support Wave Life Sciences' FTD, ALS Program
January 26, 2022
Tickers
WVE
Tags
Health Care
Phase 1 Trial
Penny Stocks
From
Benzinga
Imara To Start Testing Tovinontrine In Heart Failure Patients
January 25, 2022
Tickers
IMRA
Tags
Market News
Health Care
Trading Ideas
From
Benzinga
FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder
January 25, 2022
Tickers
FBIO
MBIO
Tags
FDA
General
Phase 2 Trial
From
Benzinga
89bio's NASH Candidate Shows Improvement In Disease Severity, Cardiovascular Health
January 25, 2022
Tickers
ETNB
Tags
Biotech
Benzinga
Non Alcoholic steatohepatitis
From
Benzinga
Tango Therapeutics' TNG908 IND For Cancer Study Gets Green Signal By FDA
January 24, 2022
Tickers
TNGX
Tags
Briefs
Benzinga
Movers
From
Benzinga
On Positive Virology Data, SAB Biotherapeutics' COVID-19 Drug To Move To Phase 3 In NIH ACTIV-2 Trial
January 24, 2022
Tickers
SABS
Tags
General
Market News
Phase 2 Trial
From
Benzinga
MediWound's EscharEx Mid-Stage Trial Meets Primary Goal In Venous Leg Ulcers
January 24, 2022
Tickers
MDWD
Tags
Phase 2 Trial
Market News
General
From
Benzinga
Mirati Therapeutics Posts 41% Objective Response Rate In Pretreated GI Cancer Patients
January 21, 2022
Tickers
MRTX
Tags
News
Briefs
Benzinga
From
Benzinga
Provention Bio Starts Mid-Stage Lupus Trial; Data Expected In 2024
January 21, 2022
Tickers
PRVB
Tags
Market News
Systemic Lupus Erythematosus
News
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.